NEW YORK--(BUSINESS WIRE)--DellaCamera Capital Management, LLC (“DellaCamera”), a long-time significant beneficial shareholder of Enzon Pharmaceuticals, Inc. (“Enzon” or the Company”) (NASDAQ: ENZN), is hopeful that the management of Enzon will provide additional information to the investment community in its upcoming conference call. Enzon announced in a February 13, 2009 press release that it will hold a conference call on February 19, 2009 at approximately 10:00 AM Eastern Time (ET) when it reports its financial results for the quarter ended December 31, 2008.
